Celldex Therapeutics
CLDX
#4507
Rank
HK$19.24 B
Marketcap
HK$244.97
Share price
4.59%
Change (1 day)
38.96%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of June 2026 : HK$6.13 Billion

According to Celldex Therapeutics's latest financial reports the company's total assets are HK$6.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$3.63 B31.95%
2022-12-31HK$2.75 B-20.51%
2021-12-31HK$3.46 B89.65%
2020-12-31HK$1.82 B90.96%
2019-12-31HK$0.95 B-21.53%
2018-12-31HK$1.22 B-50.52%
2017-12-31HK$2.46 B-17.05%
2016-12-31HK$2.97 B13.62%
2015-12-31HK$2.61 B36.01%
2014-12-31HK$1.92 B-28.53%
2013-12-31HK$2.69 B176.59%
2012-12-31HK$0.97 B27.85%
2011-12-31HK$0.76 B-11.04%
2010-12-31HK$0.85 B-21.39%
2009-12-31HK$1.08 B101.8%
2008-12-31HK$0.53 B637.86%
2007-12-31HK$73.09 M-84.71%
2006-12-31HK$0.47 B69.19%
2005-12-31HK$0.28 B-20.6%
2004-12-31HK$0.35 B46.69%
2003-12-31HK$0.24 B-11.69%
2002-12-31HK$0.27 B-34.12%
2001-12-31HK$0.41 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
HK$1.577 T 25,608.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$749.96 B 12,124.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$745.77 B 12,056.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
HK$28.49 B 364.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$1.35 B-77.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$8.75 B 42.75%๐Ÿ‡บ๐Ÿ‡ธ USA